SCHEMBL2613157

SCHEMBL2613157

Cn1c2ccccc2c2cc(N(c3ccccc3)c3ccc(-c4ccc5c(-c6ccccc6)c6ccccc6c(-c6ccccc6)c5c4)cc3)ccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSPO P30536 3/20 0.43
▸ RXRA P19793 1/20 0.43
▸ RXRB P28702 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.40
▸ GPR3 P46089 1/20 0.39
▸ HPGD P15428 3/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ LMNA P02545 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ PABPC1 P11940 1/20 0.36
▸ KIF11 P52732 1/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14521297 0.94 KDM4E (0.44) TSPORXRARXRBKDM4EGPR3
SCHEMBL14362633 0.92 GPR3 (0.46) TSPORXRARXRBKDM4EGPR3
SCHEMBL18564772 0.90 GPR3 (0.48) TSPORXRARXRBKDM4EGPR3
SCHEMBL18564781 0.90 TSPO (0.50) TSPORXRARXRBKDM4EGPR3
SCHEMBL18564782 0.90 TSPO (0.50) TSPORXRARXRBKDM4EGPR3
SCHEMBL14362490 0.89 BCHE (0.43) RXRARXRBKDM4EGPR3HPGD
SCHEMBL18564902 0.89 TSPO (0.47) TSPORXRARXRBKDM4EGPR3
SCHEMBL18564916 0.89 TSPO (0.47) TSPORXRARXRBKDM4EGPR3
SCHEMBL10162126 0.89 TSPO (0.47) TSPOKDM4EHPGDMAPTALDH1A1
SCHEMBL17051453 0.88 GPR3 (0.50) TSPORXRARXRBKDM4EGPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288012-B2 Anthracene derivatives and light-emitting devices using the anthracene derivatives SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-16 — — US disclosed
US-8288012-B2 Anthracene derivatives and light-emitting devices using the anthracene derivatives SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-16 — — US disclosed
US-20120211728-A1 Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-08-23 — — US disclosed
US-20120211728-A1 Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-08-23 — — US disclosed
EP-2031036-B1 Light-emitting element, light-emitting device, and electronic appliance SEMICONDUCTOR ENERGY LAB (JP) 2012-06-27 — — EP disclosed
EP-2444470-A1 Light-emitting element, light-emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-04-25 — — EP disclosed
US-8101289-B2 Light-emitting element, light-emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-24 — — US disclosed
US-8101289-B2 Light-emitting element, light-emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-24 — — US disclosed
US-20090058278-A1 Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-03-05 — — US disclosed
US-20090058278-A1 Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-03-05 — — US disclosed
EP-2031036-A1 Light-emitting element, light-emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-03-04 — — EP disclosed
US-20090004506-A1 Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-01-01 — — US disclosed
US-20090004506-A1 Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-01-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090004506-A1 Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives CRY1, CYP1A1, GLB1 TSPO 2918/4885RXRA 1995/4885RXRB 2937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback